Sign In
Buy MLAB
$104.38
-2.28 (-2.14%)
At Close: Jun 03, 2026
Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q3 Release
01:38pm, Monday, 01'st Feb 2021
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs Declares Quarterly Dividend
05:00pm, Tuesday, 05'th Jan 2021
LAKEWOOD, Colo., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a
Mesa Labs Reports Second Quarter Results for FY21
08:00am, Thursday, 05'th Nov 2020
LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.
Infection Control Market overview 2020, In-depth analysis with Impact of COVID-19, Types, Opportunities, Revenue and Forecast 2026
10:20am, Tuesday, 06'th Oct 2020
Oct 06, 2020 (Heraldkeepers) --
New York, October 6, 2020: The scope of the report includes a detailed study of Global Infection Control Market with the...
Infection Control Market Research Report with Detailed Analysis 2020 & Forecast to 2026
10:32am, Monday, 05'th Oct 2020
Oct 05, 2020 (Heraldkeepers) --
New York, October 5, 2020: The scope of the report includes a detailed study of Global Infection Control Market with the...
Mesa Labs (MLAB) Misses Q1 Earnings and Revenue Estimates
07:00pm, Thursday, 06'th Aug 2020
Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Reports First Quarter Results
12:00pm, Thursday, 06'th Aug 2020
LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”). Financial highlights for the quarter ended June 30
Mesa Laboratories (NASDAQ:MLAB) Shareholders Have Enjoyed An Impressive 109% Share Price Gain
01:30pm, Tuesday, 04'th Aug 2020
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...
Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline
04:33pm, Tuesday, 28'th Jul 2020
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Laboratories, Inc. (NASDAQ:MLAB) Given Average Rating of “Hold” by Brokerages
04:44am, Thursday, 16'th Jul 2020
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) have been given an average rating of “Hold” by the six brokerages that are presently covering the firm, Marketbeat.com reports. Three equities resea
MESA LABS DECLARES QUARTERLY DIVIDEND
04:00pm, Monday, 06'th Jul 2020
Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regul
Parametric Portfolio Associates LLC Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
06:14am, Friday, 03'rd Jul 2020
Parametric Portfolio Associates LLC increased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 19.1% during the first quarter, according to the company in its most recent disclosure with the S
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Balyasny Asset Management LLC
07:17am, Thursday, 25'th Jun 2020
Balyasny Asset Management LLC lowered its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 62.9% in the first quarter, according to the company in its most recent Form 13F filing with th
Mackenzie Financial Corp Sells 750 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)
07:54am, Monday, 22'nd Jun 2020
Mackenzie Financial Corp cut its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 42.9% in the first quarter, HoldingsChannel.com reports. The fund owned 1,000 shares of the medical instruments suppl
The issuance of the additional shares will result in additional gross proceeds of approximately $20.3 million to Mesa Labs, and gross proceeds for the offering as a whole of approximately $155.3 milli
